Showing 1 - 3 results of 3 for search 'M. D. Gandhi', query time: 0.02s
Refine Results
-
1
PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS-5) by M. Hamadani, Y. Linhares, M. D. Gandhi, M. Chung, H. Adamis, D. Ungar, C. Carlo-Stella, E. Kingsley, J. Depaus, S. Snauwaert, M. Kwiatek, J. López-Jiménez
Published 2022-06-01
Article -
2
PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by B. Paul, M. Liedtke, D. S. Siegel, J. Khouri, J. Hillenglass, R. Rifkin, M. D. Gandhi, A. Kin, M. Y. Levy, A. Mohrbacher, W. Schmidt, R. Silbermann, F. Cottini, D. W. Sborov, R. Walker, M. Murphy, L. Gu, A. Chen, N. Rajakumaraswamy, S. Z. Usmani
Published 2022-06-01
Article -
3
P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 ST... by H. Lee, I. W. Flinn, J. Melear, R. Ramchandren, J. Friedman, J. M. Burke, Y. Linhares, M. Raval, R. Chintapatla, T. A. Feldman, H. Yimer, M. Islas-Ohlmayer, A. Dean, V. Rana, M. D. Gandhi, J. Renshaw, A. L. Gillespie-Twardy, L. Ho, M. Puhlmann, W. Guo, C. A. Yasenchak
Published 2022-06-01
Article